Welcome to Ambrichor biobank of plasma and tissue samples
Enabling research in cancer detection
Welcome to Ambrichor biobank of plasma and tissue samples
Enabling research in cancer detection
Enabling research in cancer detection
Enabling research in cancer detection
Ambrichor collects plasma samples from a high risk, asymptomatic cohort of individuals and cancer patients. Our first indication is lung cancer, in which our region has the highest incidence worldwide. The sample collection fulfils the most rigorous pre-analytical requirements of cell free nucleic acid, exosome or epitope analysis. It also fulfils the regulatory, quality control and documentation requirements of clinical validation for registration studies submitted to Notified Bodies or US Food and Drug Administration.
Ph.D. Co-founder, Executive Chairman
Attila is the founder and Chairman of Omixon, a leader transplantation genetics. He raised or help raise over $10M VC financing and is helping various start-up companies. He has executive and management experience in AstraZeneca and Novartis. As a researcher he published over 50 publications and was cited over 1700 times.
MD, MBA Co-founder, Chief Medical Officer
Zoltan is an expert in international tissue regulation, technology transfer and distribution. He is a former deputy director general of Hungarian Blood and Transplant.
Co-founder, CBO
Alex is a business development, contracting and financial expert. He has taken a number of drug discovery and technology companies through their early growth phase and also on to exit as CEO and CFO.
Co-founder, Chief Pathologis
Marcell is pathologist with over 60 peer-reviewed publications. He is Head of Research at the Oncology Center at Semmelweis University in Budapest.
MD, PhD Co-founder, Head of Clinical and Scientific Advisory Board
Laszlo has developed two early stage lung caner tests, one acquired by Roche, one co-marketed by Randox. As a co-founder of Biosystems International he raised over $20M in capital and grants. Laszlo has conducted early stage lung cancer clinical studies of relevance to Ambrichor.
Ph.D Co-founder, Principle Investigator
Janos has co-founded and is managing director of Pentacore Labs, a next-generation sequencing-based genetic service laboratory, recently acquired by Servier. Janos has carried out a prospective thyroid cancer genetics study on high risk cohort.
Laboratory Manager
Office Manager
Marketing Manager
Copyright © 2020 Ambrichor - All Rights Reserved.
Powered by GoDaddy Website Builder